{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:17:20Z","timestamp":1788556640116,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["All Asth Clin Immun"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1710-1492-5-14","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T17:26:07Z","timestamp":1261157167000},"source":"Crossref","is-referenced-by-count":16,"title":["The anti-inflammatory effects of levocetirizine - are they clinically relevant or just an interesting additional effect?"],"prefix":"10.1186","volume":"5","author":[{"given":"Garry M","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,17]]},"reference":[{"key":"85_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(24)01328-0","volume":"49","author":"SJ Hill","year":"1997","unstructured":"Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL: International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 1997, 49: 253-278.","journal-title":"Pharmacol Rev"},{"key":"85_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1124\/jpet.102.046581","volume":"305","author":"CL Hofstra","year":"2003","unstructured":"Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP: Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther. 2003, 305: 1212-1221. 10.1124\/jpet.102.046581.","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"85_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1034\/j.1398-9995.2001.00204.x","volume":"56","author":"GF Clough","year":"2001","unstructured":"Clough GF, Boutsiouki P, Church MK: Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy. 2001, 56 (10): 985-8. 10.1034\/j.1398-9995.2001.00204.x.","journal-title":"Allergy"},{"issue":"2","key":"85_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1081-1206(10)61995-3","volume":"88","author":"JA Grant","year":"2002","unstructured":"Grant JA, Riethuisen JM, Moulaert B, DeVos C: A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol. 2002, 88 (2): 190-7.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"85_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00011-006-0075-z","volume":"55","author":"TA Popov","year":"2006","unstructured":"Popov TA, Dumitrascu D, Bachvarova A, Bocsan C, Dimitrov V, Church MK: A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. Inflamm Res. 2006, 55 (6): 241-4. 10.1007\/s00011-006-0075-z.","journal-title":"Inflamm Res"},{"key":"85_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1034\/j.1398-9995.2001.00726.x","volume":"56","author":"JL Devalia","year":"2001","unstructured":"Devalia JL, De Vos C, Hanotte F, Baltes E: A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy. 2001, 56: 50-7. 10.1034\/j.1398-9995.2001.00726.x.","journal-title":"Allergy"},{"issue":"7","key":"85_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2165\/00003495-200666070-00017","volume":"66","author":"PI Hair","year":"2006","unstructured":"Hair PI, Scott LJ: Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs. 2006, 66 (7): 973-96. 10.2165\/00003495-200666070-00017.","journal-title":"Drugs"},{"issue":"6","key":"85_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2500\/aap.2007.28.3051","volume":"28","author":"LM Dubuske","year":"2007","unstructured":"Dubuske LM: Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria. Allergy Asthma Proc. 2007, 28 (6): 724-34. 10.2500\/aap.2007.28.3051.","journal-title":"Allergy Asthma Proc"},{"key":"85_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-3038.2005.00216.x","volume":"16","author":"J de Blic","year":"2005","unstructured":"de Blic J, Wahn U, Billard E, Alt R, Pujazon MC: Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol. 2005, 16: 267-75. 10.1111\/j.1399-3038.2005.00216.x.","journal-title":"Pediatr Allergy Immunol"},{"key":"85_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1081-1206(10)61208-2","volume":"95","author":"PC Potter","year":"2005","unstructured":"Potter PC: Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol. 2005, 95: 175-85.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"85_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1081-1206(10)60662-X","volume":"99","author":"FE Simons","year":"2007","unstructured":"Simons FE, Early Prevention of Asthma in Atopic Children Study Group: H1-antihistamine treatment in young atopic children: effect on urticaria. Ann Allergy Asthma Immunol. 2007, 99 (3): 261-6.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"85_CR12","first-page":"25","volume":"37","author":"G Ciprandi","year":"2005","unstructured":"Ciprandi G, Cirillo IG, Vizzaccaro A, Tosca MA: Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study. Eur Ann Allergy Clin Immunol. 2005, 37 (1): 25-29.","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"85_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/j.1365-2222.2006.02544.x","volume":"36","author":"J Patou","year":"2006","unstructured":"Patou J, De Smedt H, van Cauwenberge P, Bachert C: Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine. Clin Exp Allergy. 2006, 36: 972-81. 10.1111\/j.1365-2222.2006.02544.x.","journal-title":"Clin Exp Allergy"},{"key":"85_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0091-6749(92)90155-U","volume":"90","author":"MV White","year":"1992","unstructured":"White MV, Kaliner MA: Mediators of allergic rhinitis. J Allergy Clin Immunol. 1992, 90: 699-704. 10.1016\/0091-6749(92)90155-U.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"85_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1517\/14656566.9.5.859","volume":"9","author":"GM Walsh","year":"2008","unstructured":"Walsh GM: A review of the role of levocetirizine as an effective therapy for allergic disease. Expert Opin Pharmacother. 2008, 9 (5): 859-67. 10.1517\/14656566.9.5.859.","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"85_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hup.962","volume":"23","author":"K McDonald","year":"2008","unstructured":"McDonald K, Trick L, Boyle J: Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol. 2008, 23 (7): 555-570. 10.1002\/hup.962.","journal-title":"Hum Psychopharmacol"},{"key":"85_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/00003495-200161020-00006","volume":"61","author":"GM Walsh","year":"2001","unstructured":"Walsh GM, Annunziatto L, Frossard N, Knol K, Levander S, Nicolas JM, Taglialatela M, Tharp MD, Tillement P, Timmerman H: New insights into the second generation antihistamines. Drugs. 2001, 61: 207-236. 10.2165\/00003495-200161020-00006.","journal-title":"Drugs"},{"key":"85_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1046\/j.1365-2745.2002.01444.x","volume":"32","author":"L Thomson","year":"2002","unstructured":"Thomson L, Blaylock MG, Sexton DW, Campbell A, Walsh GM: Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy. 2002, 32: 1187-1192. 10.1046\/j.1365-2745.2002.01444.x.","journal-title":"Clin Exp Allergy"},{"key":"85_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1365-2222.2005.02290.x","volume":"35","author":"P Wu","year":"2005","unstructured":"Wu P, Mitchell S, Walsh GM: A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy. 2005, 35: 1073-79. 10.1111\/j.1365-2222.2005.02290.x.","journal-title":"Clin Exp Allergy"},{"key":"85_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1365-2222.2004.02014.x","volume":"34","author":"A Menzies-Gow","year":"2004","unstructured":"Menzies-Gow A, Ying S, Phipps S, Kay AB: Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans. Clin Exp Allergy. 2004, 34: 1276-10.1111\/j.1365-2222.2004.02014.x.","journal-title":"Clin Exp Allergy"},{"key":"85_CR21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jaci.2004.07.054","volume":"114","author":"ML Giustizieri","year":"2004","unstructured":"Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G: H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol. 2004, 114: 1176-82. 10.1016\/j.jaci.2004.07.054.","journal-title":"J Allergy Clin Immunol"},{"key":"85_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2500\/ajr.2006.20.0796","volume":"20","author":"L Petecchia","year":"2006","unstructured":"Petecchia L, Serpero L, Silvestri M, Sabatini F, Scarso L, Rossi GA: The histamine-induced enhanced expression of vascular cell adhesion molecule-1 by nasal polyp-derived fibroblasts is inhibited by levocetirizine. Am J Rhinol. 2006, 20: 445-9. 10.2500\/ajr.2006.20.0796.","journal-title":"Am J Rhinol"},{"issue":"5","key":"85_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2500\/aap2007.28.3045","volume":"28","author":"H Hasala","year":"2007","unstructured":"Hasala H, Janka-Junttila M, Moilanen E, Kankaanranta H: Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc. 2007, 28 (5): 582-91. 10.2500\/aap2007.28.3045.","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"85_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2500\/aap.2008.29.3156","volume":"29","author":"MY Shih","year":"2008","unstructured":"Shih MY, Hsu JY, Weng YS, Fu LS: Influence of cetirizine and levocetirizine on two cytokines secretion in human airway epithelial cells. Allergy Asthma Proc. 2008, 29 (5): 480-5. 10.2500\/aap.2008.29.3156.","journal-title":"Allergy Asthma Proc"},{"key":"85_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.antiviral.2008.12.001","volume":"81","author":"YJ Jang","year":"2009","unstructured":"Jang YJ, Wang JH, Kim JS, Kwon HJ, Yeo NK, Lee BJ: Levocetirizine inhibits rhinovirus-induced ICAM-1 and cytokine expression and viral replication in airway epithelial cells. Antiviral Res. 2009, 81: 226-33. 10.1016\/j.antiviral.2008.12.001.","journal-title":"Antiviral Res"},{"key":"85_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.1365-2222.2004.01960.x","volume":"34","author":"G Ciprandi","year":"2004","unstructured":"Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA: Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin Exp Allergy. 2004, 34: 958-964. 10.1111\/j.1365-2222.2004.01960.x.","journal-title":"Clin Exp Allergy"},{"key":"85_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2125.2007.03009.x","volume":"65","author":"N Frossard","year":"2008","unstructured":"Frossard N, Strolin-Benedetti M, Purohit A, Pauli G: Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Br J Clin Pharmacol. 2008, 65: 172-9. 10.1111\/j.1365-2125.2007.03009.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"85_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1254\/jphs.08037FP","volume":"108","author":"F Mahmoud","year":"2008","unstructured":"Mahmoud F, Arifhodzic N, Haines D, Novotney L: Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis. J Pharmacol Sci. 2008, 108 (2): 149-56. 10.1254\/jphs.08037FP.","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"85_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2222.2008.03166.x","volume":"39","author":"S Vaidyanathan","year":"2009","unstructured":"Vaidyanathan S, Nair A, Barnes ML, Meldrum K, Lipworth BJ: Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis. Clin Exp Allergy. 2009, 39 (3): 409-16. 10.1111\/j.1365-2222.2008.03166.x.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"85_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF03257160","volume":"1","author":"GM Walsh","year":"2002","unstructured":"Walsh GM: Second-generation antihistamines in asthma therapy - is there a protective effect?. Am J Respir Med. 2002, 1 (1): 27-34.","journal-title":"Am J Respir Med"},{"key":"85_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2125.2004.02110.x","volume":"58","author":"DK Lee","year":"2004","unstructured":"Lee DK, Gray RD, Wilson AM, Robb FM, Soutar PC, Lipworth BJ: Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. Br J Clin Pharmacol. 2004, 58: 34-39. 10.1111\/j.1365-2125.2004.02110.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"85_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1136\/thorax.55.10.878","volume":"55","author":"BJ Lipworth","year":"2000","unstructured":"Lipworth BJ, White PS: Allergic inflammation in the unified airway: start with the nose. Thorax. 2000, 55 (10): 878-81. 10.1136\/thorax.55.10.878.","journal-title":"Thorax"},{"issue":"9","key":"85_CR33","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1365-2222.2006.02548.x","volume":"36","author":"M Pasquali","year":"2006","unstructured":"Pasquali M, Baiardini I, Rogkakou A, Riccio AM, Gamalero C, Descalzi D, Folli C, Passalacqua G, Canonica GW: Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy. 2006, 36 (9): 1161-7. 10.1111\/j.1365-2222.2006.02548.x.","journal-title":"Clin Exp Allergy"},{"key":"85_CR34","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/j.1365-2133.2006.07548.x","volume":"155","author":"M Caproni","year":"2006","unstructured":"Caproni M, Volpi W, Giomi B, Torchia D, Del Bianco E, Fabbri P: Cellular adhesion molecules in chronic urticaria: modulation of serum levels occurs during levocetirizine treatment. Br J Dermatol. 2006, 155: 1270-4. 10.1111\/j.1365-2133.2006.07548.x.","journal-title":"Br J Dermatol"}],"container-title":["Allergy, Asthma & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1710-1492-5-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1710-1492-5-14\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1710-1492-5-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:32:07Z","timestamp":1739485927000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/1710-1492-5-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1186\/1710-1492-5-14","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]},"article-number":"14"}}